Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (18)

2024

  1. Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human

    Vascular Pharmacology, Vol. 155

2023

  1. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  2. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

  3. Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension

    American Journal of Respiratory Cell and Molecular Biology, Vol. 69, Núm. 2, pp. 147-158

  4. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities

    PLoS pathogens, Vol. 19, Núm. 1, pp. e1011063

  5. The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit

    Biomedicine and Pharmacotherapy, Vol. 164

2021

  1. Oxygen-sensitivity and pulmonary selectivity of vasodilators as potential drugs for pulmonary hypertension

    Antioxidants, Vol. 10, Núm. 2, pp. 1-14

  2. Restoration of vitamin d levels improves endothelial function and increases task-like k+ currents in pulmonary arterial hypertension associated with vitamin d deficiency

    Biomolecules, Vol. 11, Núm. 6

2020

  1. Uncovered Contribution of Kv7 Channels to Pulmonary Vascular Tone in Pulmonary Arterial Hypertension

    Hypertension, Vol. 76, Núm. 4, pp. 1134-1146

  2. Vitamin D deficiency downregulates TASK-1 channels and induces pulmonary vascular dysfunction

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 319, Núm. 4, pp. L627-L640

2019

  1. Dietary Cocoa Prevents Aortic Remodeling and Vascular Oxidative Stress in Diabetic Rats

    Molecular Nutrition and Food Research, Vol. 63, Núm. 18

  2. Elevated pulmonary arterial pressure in Zucker diabetic fatty rats

    PLoS ONE, Vol. 14, Núm. 1

  3. Th2 CD4+ T Cells Are Necessary and Sufficient for Schistosoma-Pulmonary Hypertension

    Journal of the American Heart Association, Vol. 8, Núm. 15, pp. e013111

  4. miR-1 induces endothelial dysfunction in rat pulmonary arteries

    Journal of Physiology and Biochemistry, Vol. 75, Núm. 4, pp. 519-529

  5. miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries

    Journal of Physiology, Vol. 597, Núm. 4, pp. 1185-1197

2018

  1. Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome

    Scientific Reports, Vol. 8, Núm. 1

  2. Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/ perfusion matching

    PLoS ONE, Vol. 13, Núm. 1

2016

  1. Effects of quercetin in a rat model of hemorrhagic traumatic shock and reperfusion

    Molecules, Vol. 21, Núm. 12